Figure 4From: Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model Proportion of drug, physician, cardiovascular and type 2 diabetes costs to total annual costs for patients with hypertension and MetS; 2008.Back to article page